Physical performance before and after hematopoietic stem cell transplantation in pediatric patients: a potential role for prehabilitation

被引:1
作者
den Hartog, Emma [1 ]
Lindemans, Caroline A. [1 ,2 ]
Fiocco, Marta [1 ,3 ,4 ]
Tissing, Wim J. E. [1 ,5 ]
Verwaaijen, Emma J. [1 ]
机构
[1] Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands
[2] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Pediat, Utrecht, Netherlands
[3] Leiden Univ, Med Ctr, Dept Biomed Data Sci, Sect Med Stat, Leiden, Netherlands
[4] Leiden Univ, Math Inst, Leiden, Netherlands
[5] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Pediat Oncol & Hematol, Groningen, Netherlands
关键词
BONE-MARROW TRANSPLANT; CHILDHOOD-CANCER; MUSCLE MASS; CHILDREN; SURVIVORS; CAPACITY;
D O I
10.1038/s41409-024-02390-4
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
The trajectory of hematopoietic stem cell transplantation (HSCT) is often accompanied by physically disabling complications that impair physical performance of pediatric patients. However, knowledge about when impairments in physical performance arise and the factors contributing to these impairments is limited. Therefore, we conducted a retrospective analysis of physical performance 100 days post-HSCT in patients aged 3-18 years. Additionally, we aim to elucidate the relationship between pre- and post-HSCT physical performance and to unravel the impact of intensive HSCT procedures on post-HSCT physical performance. To explore associations between physical performance outcomes post-HSCT and covariates, linear regression models were estimated. Seventy-seven patients were included with a median age of 11.8 years (interquartile range: 5.9, 14.8). Patients had lower hip flexion muscle strength and appendicular skeletal muscle mass and a slower rising from the floor time 100 days post-HSCT compared to average values of the normal population. Pre-HSCT physical performance was positively associated with physical performance post-HSCT, independent of age, the cumulative glucocorticoids dosage administered and the total duration of hospitalization during the HSCT trajectory. This explorative study highlights the potential role of prehabilitation in enhancing physical performance of pediatric HSCT patients.
引用
收藏
页码:1499 / 1505
页数:7
相关论文
共 50 条
  • [21] Pharmacokinetics of Treosulfan in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation
    ten Brink, Marloes H.
    Ackaert, Oliver
    Zwaveling, Juliette
    Bredius, Robbert G. M.
    Smiers, Frans J.
    den Hartigh, Jan
    Lankester, Arjan C.
    Guchelaar, Henk-Jan
    THERAPEUTIC DRUG MONITORING, 2014, 36 (04) : 465 - 472
  • [22] Skin Biopsy in Pediatric Oncology/Hematopoietic Stem Cell Transplantation Patients
    Bui, Justin
    Harvey, Nathan T.
    Berry, Bligh
    Chan, Jonathan
    Ramachandran, Shanti
    Gough, Hazel
    Wood, Benjamin A.
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2022, 44 (10) : 728 - 733
  • [23] Salivary Changes before and after Hematopoietic Stem Cell Transplantation: A Systematic Review
    van Leeuwen, Stephanie J. M.
    Potting, Carin M. J.
    Huysmans, Marie-Charlotte D. N. J. M.
    Blijlevens, Nicole M. A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (06) : 1055 - 1061
  • [24] The emerging role of nutritional support in the supportive care of pediatric patients undergoing hematopoietic stem cell transplantation
    Muratore, Edoardo
    Leardini, Davide
    Baccelli, Francesco
    Venturelli, Francesco
    Cerasi, Sara
    Zanaroli, Andrea
    Lanari, Marcello
    Prete, Arcangelo
    Masetti, Riccardo
    Zama, Daniele
    FRONTIERS IN NUTRITION, 2023, 10
  • [25] Safety and Utility of Liver Biopsy After Pediatric Hematopoietic Stem Cell Transplantation
    Oshrine, Benjamin
    Lehmann, Leslie E.
    Duncan, Christine N.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2011, 33 (03) : E92 - E97
  • [26] Etiology, characteristics and outcome of seizures after pediatric hematopoietic stem cell transplantation
    Cordelli, Duccio Maria
    Masetti, Riccardo
    Zama, Daniele
    Gueraldi, Daniela
    Rondelli, Roberto
    Cottone, Carlo
    Prete, Arcangelo
    Pession, Andrea
    Franzoni, Emilio
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2014, 23 (02): : 140 - 145
  • [27] Osteochondroma after pediatric hematopoietic stem cell transplantation: report of eight cases
    P Bordigoni
    R Turello
    L Clement
    P Lascombes
    B Leheup
    MA Galloy
    F Plenat
    Bone Marrow Transplantation, 2002, 29 : 611 - 614
  • [28] Lethal Pulmonary Complications After Pediatric Allogeneic Hematopoietic Stem Cell Transplantation
    Fazekas, Tamas
    Attarbaschi, Andishe
    Lawitschka, Anita
    Seidel, Markus
    Poetschger, Ulrike
    Peters, Christina
    Mann, Georg
    Gadner, Helmut
    Matthes-Martin, Susanne
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2012, 31 (02) : 115 - 119
  • [29] Changes of Bone Density in Pediatric Patients with β-thalassemia Major after Allogenic Hematopoietic Stem Cell Transplantation
    Hamidieh, Amir Ali
    Hamidi, Zohreh
    Nedaeifard, Leila
    Heshmat, Ramin
    Alimoghaddam, Kamran
    Larijani, Bagher
    Ghavamzadeh, Ardeshir
    Mohajeri-Tehrani, Mohammad Reza
    ARCHIVES OF IRANIAN MEDICINE, 2013, 16 (02) : 88 - 92
  • [30] DEFERASIROX USE AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PEDIATRIC PATIENTS WITH β-THALASSEMIA MAJOR: Preliminary Results
    Unal, Sule
    Kuskonmaz, Baris
    Hazirolan, Tuncay
    Eldem, Gonca
    Aytac, Selin
    Cetin, Mualla
    Uckan, Duygu
    Gumruk, Fatma
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2010, 27 (06) : 482 - 489